Group items tagged

What's more said Hurley at a media conference to release the poll findings, "it's a grim and concerning reality that despite the fact incidents are happening almost daily, workers fear reprisal and incidents are under-reported". The majority of respondents said that in the last year, in the workplace they had experienced at least one incident of physical violence, but many said they had experienced nine or more occurrences.

59 per cent of the poll respondents are RPNs or PSWs. Of those respondents 73 per cent are women. 41 per cent of respondents provided other important support services at NBRHC. A high number, 81 per cent also indicated they witnessed incidents of physical and non-physical violence toward co-workers in the last year.

40 per cent of respondents had experienced sexual harassment or sexual assault either physical or non-physical in the last year. "These workers are largely women. This is violence against women that's being allowed to happen here. In what other workplace would sexual harassment and sexual violence, at this level be tolerated?" Asked Sharon Richer, OCHU north eastern

Ontario vice-president. The poll also points to a climate of intimidation in the workplace and an under-reporting of incidents. 51 per cent responded that they are afraid of reprisal if they speak up about an incident of violence. The poll shows that there are far-more incidents of violence experienced by respondents than are actually reported. "The findings show violence is pervasive in this workplace. It's an unsafe work environment where something is standing in the way of workers reporting incidents. There is a fear of reprisal if you report. There is also under-reporting, which is linked to reprisal. There is no doubt people are afraid to speak out," said Hurley. FOR FURTHER INFORMATION PLEASE CONTACT: Michael Hurley OCHU President 416-884-0770 Sharon Richer OCHU, Vice-President North Eastern Ontario 705-280-0911 Stella Yeadon CUPE Communications 416-559-9300 Source: Ontario Council of Hospital Unions (OCHU)

35,000 direct job losses for the public sector and somewhere between 10,000 and 15,000 indirect job losses in the private sector, throwing the economy into a deep recession,” says Lucas.

On top of that,” says Lucas, “after saying they were opposed to P3s – so-called public-private-partnerships – during the election campaign, the Liberal government now says it wants to ‘explore’ privatized health care and other vital public services.

There’s not yet even an application to open a pay-for-plasma clinic in Alberta, but the issue already appears to be reaching crisis levels.

Never mind the fact that this practice has been ongoing for decades in Manitoba and for several years in other countries, Alberta’s health minister is being urged to take swift action to put a stop to it — and she appears willing to do so. 

In February, a company called Canadian Plasma Resources opened a clinic in Saskatoon. Plasma collected is used to make pharmaceutical products and other medical therapies, and donors are compensated to the tune of a $25 pre-loaded credit card. They’re now looking to open a clinic in British Columbia and possibly in Alberta and Manitoba in the coming years.

affordable generic medicines

corporate-investor rights agreement, not a trade agreement,”

pharmaceutical companies

Council of Canadians is presenting three experts to discuss the TPP: veterinary scientist Shiv Chopra, sacked by Health Canada for resisting pressure to approve Monsanto’s bovine growth hormone; filmmaker Paul Manly on investor state resolution (a corporate attack on tax money by suing governments for estimated lost profits); and Brenda Sayers, Hupacasath leader of the legal challenge to the Canada-China trade deal.

Ms. Banerji said Inuit may also have a genetic predisposition to these types of infections. But until those environmental conditions are addressed, a medicine called palivizumab is effective against such infections. In 2010, the Canadian Pediatric Society recommended that "consideration should be given" to administering a preventative drug to all fullterm Inuit infants younger than six months of age in areas with high rates of hospital admissions for respiratory infections. The territory currently gives palivizumab only to children born prematurely or who have chronic heart or lung conditions. The region of Nunavik has recently changed its policy and will administer the drug to all newborns. Palivizumab costs about $6,500 an infant. Ms. Banerji said the cost of treatment, including flying sick kids south, is so high that it would be cheaper to give it to all babies born in the worst areas. She says that policy would save $36,000 for each hospital admission avoided. It would also save wear and tear on families. "A mother has to either come with her two-month-old baby to the hospital in Ottawa and leave all the rest of the kids behind, or the baby's there all alone. It has a huge societal impact." The government of Nunavut has received a copy of the paper. The territory's chief medical officer of health was travelling Tuesday and not immediately available to react to its findings. © 2016 The Globe and Mail Inc. All Rights Reserved.